Latin American and Caribbean research contributions to tackle challenges posed by brain diseases
Every year there are nearly ten million new cases of dementia globally, of which Alzheimer s Disease (AD) is the most common form, accounting for around 60-70% of cases. This special supplement, published in the
Journal of Alzheimer s Disease, focuses on the challenges posed by brain disease and presents significant research contributions from Latin America and the Caribbean that address these challenges to help improve the lives of individuals with AD.
AD is a complex, multifactorial neurodegenerative disorder that represents a major and increasing global health challenge. Neuroscience is making strides in unraveling the brain s secrets through translational research and drug discovery in order to improve the lives of individuals with a wide variety of neurological and psychiatric disorders such as AD, Parkinson s disease, schizophrenia, depression, traumatic brain injury, epilepsy,
Alphagalileo > Item Display alphagalileo.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alphagalileo.org Daily Mail and Mail on Sunday newspapers.
Image
Dr. Silvia Cruz
Silvia Cruz, Ph.D., is an international expert on the neurobiology of addiction who was a 1996-1997 NIDA INVEST Fellow at Virginia Commonwealth University (VCU) with Robert Balster, Ph.D. In 2010, she spent a year as an invited researcher at Mexico’s
Ramón de la Fuente Muñiz National Institute of Psychiatry
, where she focused on epidemiology, anthropology, and sociology. Dr. Cruz is currently a full professor at Mexico’s Center of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav), where she previously served as graduate program coordinator and chair of the Department of Pharmacobiology. This interview is based on her webinar for the International Society of Addiction Medicine (ISAM) Neuroscience Interest Group series, “In Love with Addiction Neuroscience.”